|
Volumn 65, Issue 1, 2005, Pages 89-90
|
Treated pregnant patients with antiphospholipid syndrome are particularly susceptible to pre-eclampsia and fetal growth retardation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA2 GLYCOPROTEIN 1;
CARDIOLIPIN ANTIBODY;
CORTICOSTEROID;
IMMUNOGLOBULIN G;
LOW MOLECULAR WEIGHT HEPARIN;
LUPUS ANTICOAGULANT;
PHOSPHOLIPID ANTIBODY;
PROTHROMBIN;
ANTIPHOSPHOLIPID SYNDROME;
CONNECTIVE TISSUE DISEASE;
DISEASE PREDISPOSITION;
FETUS WASTAGE;
HUMAN;
INTRAUTERINE GROWTH RETARDATION;
LETTER;
PREECLAMPSIA;
PREGNANCY;
PREGNANCY COMPLICATION;
PRIORITY JOURNAL;
RECURRENT ABORTION;
SPONTANEOUS ABORTION;
TROPHOBLAST;
ADULT;
ANTIPHOSPHOLIPID SYNDROME;
FEMALE;
FETAL GROWTH RETARDATION;
HUMANS;
PRE-ECLAMPSIA;
PREGNANCY;
PREGNANCY COMPLICATIONS, HEMATOLOGIC;
|
EID: 13244253767
PISSN: 01650378
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jri.2004.09.005 Document Type: Letter |
Times cited : (2)
|
References (4)
|